FDA Inspection 1243056 — Barnaby Henare Montgomery, M.D.

Barnaby Henare Montgomery, M.D. — FEI 3030419062

The FDA completed an inspection of Barnaby Henare Montgomery, M.D. on May 10, 2024 in Auckland. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 10, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Auckland (New Zealand)

Additional Details

Clinical Investigator (CI)